Published March 14, 2024
| Version v1
Journal article
Open
Antibody Characterization Report for hnRNP A1 (Heterogeneous nuclear ribonucleoprotein A1)
Creators
-
1.
Montreal Neurological Institute and Hospital
- 2. Advanced BioImaging Facility (ABIF)
-
3.
McGill University
Description
This report presents a guide to selecting high-quality commercial antibodies against Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) by Western blot, immunoprecipitation and immunofluorescence, using a standardized experimental protocol comparing read-outs in knockout cell lines and isogenic parental controls.
This study was funded in part by the ALS-Reproducible Antibody Platform (ALS-RAP), established as a public-private partnership by three prominent ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.
Files
hnRNP A1_HNRNPA1_YCharOS report.pdf
Files
(1.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:011bd96d6d0bfc6ab5fddb276c42781e
|
1.4 MB | Preview Download |